Clinical trials are the cornerstone of pharmaceutical innovation, providing the evidence necessary to bring safe and … The Biggest Reasons Clinical Trials Fail to ScaleRead more
Industry Landscape
Articles under this category focus on macro trends, big pharma behavior, and annual outlooks.
Why Many Biotech Startups Never Make It Past Early Trials
Over 90% of biotech startups never advance beyond early clinical trials, a statistic that underscores the … Why Many Biotech Startups Never Make It Past Early TrialsRead more
SMS Marketing Compliance in Pharma
Navigating Regulation, Privacy, and Patient Engagement Pharmaceutical companies increasingly rely on mobile messaging to reach patients, … SMS Marketing Compliance in PharmaRead more
User Experience Optimization in the Pharmaceutical Industry
The New Competitive Frontier in Pharma For decades, pharmaceutical success hinged on clinical efficacy, regulatory approval, … User Experience Optimization in the Pharmaceutical IndustryRead more
Why Phase II Clinical Trials Are the Graveyard of Drug Development
Nearly 60 percent of drug candidates that enter Phase II clinical trials never advance to Phase … Why Phase II Clinical Trials Are the Graveyard of Drug DevelopmentRead more
What Happens When Pharma Ignores Real-World Evidence
In 2023, nearly half of drugs approved by the U.S. Food and Drug Administration faced post-launch … What Happens When Pharma Ignores Real-World EvidenceRead more
Email Segmentation in Pharma Campaigns: Precision, Compliance, and the Next Frontier of Patient and HCP Engagement
Pharmaceutical marketers face a dual mandate: deliver clinically relevant information while meeting strict regulatory obligations. Email … Email Segmentation in Pharma Campaigns: Precision, Compliance, and the Next Frontier of Patient and HCP EngagementRead more
Why Patient Recruitment Is the Biggest Problem in Clinical Trials Today
Patient recruitment remains the single most persistent bottleneck in clinical trials today. Despite advances in trial … Why Patient Recruitment Is the Biggest Problem in Clinical Trials TodayRead more
How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical Market
In the United States, drug approval timelines are becoming harder to predict. Despite record investment in … How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical MarketRead more
Why Great Science Often Fails Commercially in Pharma
In the United States, bringing a new drug to market now costs more than $2 billion on average … Why Great Science Often Fails Commercially in PharmaRead more